| 【Fixed Income Research】JINKE – We see value in JINKE 24 at 90.5 (YTM 10.8%) |
| 【Fixed Income Research】Takeaways from Corporate Day - More Clarity Amid Volatility |
| 【Company Research】I-Mab BioPharma (IMAB US) – I-Mab expands portfolio through cutting-edge mRNA and AI technology platforms |
| 【Fixed Income Research】First take from Corporate Day: Ehouse - Short-dated sweet spot |
| 【Sector Research】China AI surveillance – 2Q21 preview: eye on gross margin |
| 【Fixed Income Research】First Take from Corporate Day: Sinic - Fundamental is on-track but refinancing remains a concern |
| 【Fixed Income Research】First Take from Corporate Day: Redsun - Fairly valued |
| 【Fixed Income Research】First take from Corporate Day: Central China - Weak contracted sales year-to-date |
| 【Fixed Income Research】First take from Corporate Day: Zhenro - Front end bonds are good carry play |
| 【Fixed Income Research】CHGRAU's tender offer should boost CHIGRA 8 ⅝ 04/08/22 to par |
公司地址：香港中環花園道三號冠君大廈45-46樓
電話：（852） 3900-0888 傳真：（852） 3761-8788
招銀國際版權所有 Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
